Expertise in
14
conditions

Dr. Robert A. Hauser

Neurology
USF Health Parkinsons Disease & Movement Disorders
4001 E Fletcher Ave Fl 6, 
Tampa, FL 
Accepting New Patients
Expertise in
14
conditions
USF Health Parkinsons Disease & Movement Disorders
4001 E Fletcher Ave Fl 6, 
Tampa, FL 

Overview

Robert Hauser is a Neurologist practicing medicine in Tampa, Florida.

Dr. Hauser is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Parkinson's Disease, Movement Disorders, Drug Induced Dyskinesia, and Tardive Dyskinesia.

He is actively involved in clinical research, co-authoring 202 peer reviewed articles and participating in 14 clinical trials. Dr. Hauser is currently accepting new patients.

Specialties

Neurology

Licenses

Psychiatry & Neurology in FL

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Freedom Health
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

USF Health Parkinsons Disease & Movement Disorders
4001 E Fletcher Ave Fl 6, Tampa, FL 33613

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

14 Clinical Trials

Rostock International Parkinson's Disease Study: an International, Multicenter, Epidemiological Observational Study
Rostock International Parkinson's Disease Study: an International, Multicenter, Epidemiological Observational Study
Enrollment Status: Completed
Publish Date: April 13, 2026
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of CVN424 in Parkinson's Disease Patients With Motor Fluctuations
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of CVN424 in Parkinson's Disease Patients With Motor Fluctuations
Enrollment Status: Completed
Publish Date: July 03, 2024
Intervention Type: Drug
Study Drug: CVN424
Study Phase: Phase 2
A Multicenter, Non-Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Orally Administered ENT-01 in Improving Constipation and Neurologic Symptoms in Patients With Parkinson's Disease and Constipation Over a 14-week Period
A Multicenter, Non-Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Orally Administered ENT-01 in Improving Constipation and Neurologic Symptoms in Patients With Parkinson's Disease and Constipation Over a 14-week Period
Enrollment Status: Terminated
Publish Date: March 19, 2024
Intervention Type: Drug
Study Drug: ENT-01
Study Phase: Phase 2
A Multicenter, Open Label Study to Evaluate Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Dementia.
A Multicenter, Open Label Study to Evaluate Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Dementia.
Enrollment Status: Withdrawn
Publish Date: March 01, 2024
Intervention Type: Drug
Study Drug: ENT-01
Study Phase: Phase 1
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate Safety, Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease-Related Constipation (KARMET)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate Safety, Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease-Related Constipation (KARMET)
Enrollment Status: Completed
Publish Date: February 20, 2024
Intervention Type: Drug
Study Drug: ENT-01
Study Phase: Phase 2
A Phase 2, Randomized, Double-Blind, Multicenter, Placebo Controlled Study to Evaluate the Safety and Efficacy of Intramuscular ABP-450 (prabotulinumtoxinA) Injection for the Treatment of Cervical Dystonia
A Phase 2, Randomized, Double-Blind, Multicenter, Placebo Controlled Study to Evaluate the Safety and Efficacy of Intramuscular ABP-450 (prabotulinumtoxinA) Injection for the Treatment of Cervical Dystonia
Enrollment Status: Completed
Publish Date: February 14, 2024
Intervention Type: Drug
Study Drug: ABP-450
Study Phase: Phase 2
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Enrollment Status: Completed
Publish Date: December 27, 2023
Intervention Type: Other, Drug
Study Phase: Phase 1/Phase 2
The Parkinson's Progression Markers Initiative (PPMI)
The Parkinson's Progression Markers Initiative (PPMI)
Enrollment Status: Completed
Publish Date: November 14, 2023
Intervention Type: Drug
Study Drug: DaTscan
Study Phase: Phase 2
RESTORE: A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy
RESTORE: A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy
Enrollment Status: Completed
Publish Date: August 23, 2023
Intervention Type: Drug
Study Drug: Droxidopa
Study Phase: Phase 4
Parkinson's Foundation Quality Improvement Initiative
Parkinson's Foundation Quality Improvement Initiative
Enrollment Status: Completed
Publish Date: July 14, 2023
View 9 Less Clinical Trials

202 Total Publications

Device shifting and embolization of a new generation percutaneous left atrial appendage occluding device. Novel insights on Watchman FLX PRO.
Device shifting and embolization of a new generation percutaneous left atrial appendage occluding device. Novel insights on Watchman FLX PRO.
Journal: Cardiovascular revascularization medicine : including molecular interventions
Published: July 20, 2026
Similar Doctors
Expertise in
25
conditions
Expertise in
25
conditions
Referral may be required

USF Health Department Of Neurology

4001 East Fletcher Avenue, 
Tampa, FL 
 (2.3 miles away)
813-821-8017
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Theresa Zesiewicz is a Neurologist practicing medicine in Tampa, Florida. Dr. Zesiewicz is highly rated in 25 conditions, according to our data. Her clinical expertise encompasses Hereditary Ataxia, Movement Disorders, Drug Induced Dyskinesia, Spinocerebellar Ataxia, and Deep Brain Stimulation. Dr. Zesiewicz is currently accepting new patients.

Expertise in
16
conditions
Expertise in
16
conditions
Referral may be required

Univ. Medical Service Association Inc.

2 Tampa General Cir, 
Tampa, FL 
 (10.2 miles away)
813-259-0965
Languages Spoken:
English, Russian
See accepted insurances
Accepting New Patients
Offers Telehealth

Maxim Mokin is a Neurologist practicing medicine in Tampa, Florida. Dr. Mokin is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Stroke, Brain Aneurysm, Apoplexy, Thrombectomy, and Stent Placement. Dr. Mokin is currently accepting new patients.

Expertise in
13
conditions
Expertise in
13
conditions
Referral may be required

Univ. Medical Service Association Inc.

2 Tampa General Cir, 
Tampa, FL 
 (10.2 miles away)
813-396-9478
Languages Spoken:
English, French, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Selim Benbadis is a Neurologist practicing medicine in Tampa, Florida. Dr. Benbadis is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Seizures, Epilepsy, Generalized Tonic-Clonic Seizure, Absence Seizure, and Gastrostomy. Dr. Benbadis is currently accepting new patients.

Frequently Asked Questions about Dr. Robert A. Hauser

How do I make an appointment with Dr. Robert A. Hauser?

You can book an appointment with Dr. Robert A. Hauser by calling their office at 813-396-0751. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Robert A. Hauser a top-rated expert for Parkinson's Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Robert A. Hauser is classified as an Elite expert for Parkinson's Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Robert A. Hauser specialize in?

While Dr. Robert A. Hauser is a Neurology, they have specific expertise in Parkinson's Disease, Movement Disorders, and Drug Induced Dyskinesia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.

Does Dr. Robert A. Hauser participate in research or clinical trials?

Yes. Dr. Robert A. Hauser has published 202 articles and abstracts on conditions like Parkinson's Disease. You can view a list of Dr. Robert A. Hauser's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Robert A. Hauser accept my insurance?

Dr. Robert A. Hauser accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 813-396-0751 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hauser's expertise for a condition
ConditionClose
View All 8 Elite Conditions
View All 11 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile